SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-331182
Filing Date
2013-08-13
Accepted
2013-08-12 17:32:11
Documents
14
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d539909d10q.htm 10-Q 374570
2 EX-10.2 d539909dex102.htm EX-10.2 11788
3 EX-10.3 d539909dex103.htm EX-10.3 1184040
4 EX-31.1 d539909dex311.htm EX-31.1 5715
5 EX-31.2 d539909dex312.htm EX-31.2 5717
6 EX-32.1 d539909dex321.htm EX-32.1 4902
13 GRAPHIC g539909g37z65.jpg GRAPHIC 5542
14 GRAPHIC g539909img1.jpg GRAPHIC 3443
  Complete submission text file 0001193125-13-331182.txt   5061559

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT prta-20130630.xml EX-101.INS 375493
8 XBRL TAXONOMY EXTENSION SCHEMA prta-20130630.xsd EX-101.SCH 26962
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prta-20130630_cal.xml EX-101.CAL 39502
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prta-20130630_def.xml EX-101.DEF 87160
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE prta-20130630_lab.xml EX-101.LAB 209240
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prta-20130630_pre.xml EX-101.PRE 165015
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 353 1 709 4700
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 131030690
SIC: 2834 Pharmaceutical Preparations